Clinical Trials Directory

Trials / Completed

CompletedNCT04426643

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells Mixed With Collagen Gel and Injected Submucousely

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Treatment of patients with urinary incontinence after prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Detailed description

During the implementation of the project, it is planned to develop a method for the treatment of men urinary incontinence caused by prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen. The positive outlook for the effectiveness of MSCs is due to the following: * the ability of MSCs to stimulate tissue regeneration * positive results of preclinical studies of the method of treatment of urinary incontinence in animals. In study planing to include 5 patients. MSCs will be isolated from adipose tissue, cultured and then transplanted back to the periurethral area by five point injection in rhabdosphincter and submucosal space of urethra using the cystourethroscope. For injection in submucosal space MSCs (20\*10\^6 cells) will be mixed with collagen solution (3,5% w\|w). Follow up patients monitoring will occur at 1,3,6 and 12 months after injection.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous adipose-derived mesenchymal stem cellsAutologous adipose-derived mesenchymal stem cells mixed with collagen solution injected in submucosal space
OTHERStandard treatment according to the Clinical protocolsStandard treatment according to the Clinical protocols

Timeline

Start date
2020-08-01
Primary completion
2021-02-20
Completion
2021-03-31
First posted
2020-06-11
Last updated
2021-05-25

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT04426643. Inclusion in this directory is not an endorsement.